Drawing for GMA

USPTO serial 76245311

GMA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DALIER, JOHN DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert J. Kenney

ROBERT J KENNEY BIRCH, STEWART, KOLASCH & BIRCH, LLPP O BOX 747FALLS CHURCH, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical research chemicals, namely, buffers, chemical reagents, fluorescent compounds, fluorescent-labeled compounds, nucleotides, nucleic acids, olingonucleotides all for use in medical diagnosis, testing of clinical samples, medical research, veterinary medical research, genotyping, detection of mutations and polymorphisms, the medical determination of the genetic basis of disease, the medical determination of the genetic basis of drug response and the medical analysis, characterization and identification of nucleic acids; microarrays and macroarrays consisting of nucleic acids and oligonucleotides applied to substrates and supports optionally also carrying chemical reagents, fluorescent compounds, fluorescent-labeled compounds all for use in medical diagnosis, medical testing of clinical samples, medical research, veterinary medical research, genotyping, detection of mutations and polymorphisms, the medical determination of the genetic basis of disease, the medical determination of the genetic basis of disease, the medical determination of genetic basis of drug response and the analysis, characterization and identification of nucleic acidsACTIVE—
042Medical diagnosis, testing of clinical samples, medical research, detection of pathogens, identification of pathogens, diagnosis of disease, diagnosis of infection, veterinary research, genotyping, detection of mutations and polymorphisms, gene expression profiling, determination of the genetic basis of disease, determination of the genetic basis of drug response, nucleic acid analysis, nucleic acid characterization, nucleic acid identification and plant research for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 2, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 25, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 3, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2002NPUBNOTICE OF PUBLICATION—
Sep 18, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2002ZZZZALLOWANCE/COUNT WITHDRAWN—
May 15, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance